Edition:
United Kingdom

Eisai Co Ltd (4523.T)

4523.T on Tokyo Stock Exchange

10,645JPY
25 Sep 2018
Change (% chg)

¥375 (+3.65%)
Prev Close
¥10,270
Open
¥10,395
Day's High
¥10,695
Day's Low
¥10,355
Volume
1,308,300
Avg. Vol
1,428,885
52-wk High
¥11,490
52-wk Low
¥5,402

Summary

Name Age Since Current Position

Yasuhiko Kato

71 2018 Chairman of the Board of Directors, Independent Director

Haruo Naito

70 2014 Chief Executive Officer, Representative Executive Officer, Director

Ryohei Yanagi

56 2015 Managing Executive Officer, Chief Financial Officer, Chief IR Officer

Hideki Hayashi

60 2016 Representative Executive Officer, Chief Information Officer

Junichi Asatani

57 2014 Executive Officer, Chief Compliance Officer

Kenta Takahashi

58 2016 Managing Executive Officer, General Counsel, President of Subsidiary

Ivan Cheung

41 2016 Managing Executive Officer, President of Neurology Business Group, President of America Region, Chairman & Chief Executive Officer of Subsidiary

Edward Geary

55 2013 Managing Executive Officer, Chief Medical Officer, Chief Director of Corporate Medical Affairs

Gary Hendler

51 2016 Managing Executive Officer, President of EMEA Region, Chief Commercial Officer of Oncology Business Group, President & Chief Executive Officer of Subsidiary

Terushige Iike

54 2016 Managing Executive Officer, President of Oncology Business Group

Masatomi Akana

51 2017 Executive Officer

Yanhui Feng

46 2016 Executive Officer, General Manager of Subsidiaries

Yasunobu Kai

56 2018 Executive Officer, Chief Planning Officer of Oncology Business Group, Director of Planning of Oncology Business Group

Shohei Kanazawa

53 2017 Executive Officer, President of Consumer hhc Business Unit

Hiroyuki Kato

61 2018 Executive Officer, Chief Quality Officer

Yoshiteru Kato

58 2017 Executive Officer, President of Eisai Demand Chain Systems

Teiji Kimura

55 2016 Executive Officer, Chief Discovery Officer of Neurology Business Group

Hiroyuki Kobayashi

44 2017 Executive Officer, Chief Medical Officer of Japan & Asia, Chief Director of Medical

Lynn Kramer

67 2016 Executive Officer, Chief Clinical Officer of Neurology Business Group, Chief Medical Officer of Neurology Business Group

Masayuki Miyajima

56 2016 Executive Officer, President of Eisai Japan

Kazumasa Nagayama

38 2018 Executive Officer, Chief Strategy Officer, Director of Corporate Strategy

Akiko Nakahama

50 2018 Executive Officer, Manager of Medicine Development Center

Takashi Ohwa

55 2016 Executive Officer, Chief Medicine Creation Officer of Oncology Business Group, Chief Discovery Officer of Oncology Business Group

Shaji Procida

47 2014 Executive Officer, President of Subsidiary

Sayoko Sasaki

49 2018 Executive Officer, President of Asia & Latin America Region

Alexander Scott

53 2016 Executive Officer, Chief Strategy Officer in Neurology Business Group, Director of Strategy in Neurology Business Group

Mitsuaki Tanaka

56 2018 Executive Officer, Chief Planning Officer, Director of Corporate Planning

Hidenori Yabune

48 2017 Executive Officer, Chief Director of Regional Cooperation Metropolitan Area of Eisai Japan

Tatsuyuki Yasuno

50 2018 Executive Officer

Yasushi Okada

59 2017 Representative Executive Officer, Chief Talent Officer

Hirokazu Kanai

58 2016 Director

Noboru Naoe

62 2014 Director

Yutaka Tsuchiya

66 2017 Director

Bruce Aronson

66 2017 Independent Director

Shuzo Kaihori

70 2018 Independent Director

Tamaki Kakizaki

57 2016 Independent Director

Ryuichi Murata

70 2018 Independent Director

Daiken Tsunoda

51 2016 Independent Director

Hideyo Uchiyama

65 2018 Independent Director

Shinya Watanabe

2016 Director of Accounting in Main Finance & Accounting Unit

Biographies

Name Description

Yasuhiko Kato

Mr. Yasuhiko Kato has been serving as Chairman of the Board of Directors and Independent Director in Eisai Co., Ltd. since June 2018. He is also working for Mitsui E&S Holdings Co., Ltd. He used to work for Mitsui Zosen Europe Ltd. and Mitsui Babcock Energy Limited.

Haruo Naito

Mr. Haruo Naito has been serving as Chief Executive Officer, Representative Executive Officer and Director in Eisai Co., Ltd. since June 2014. He is also working for The Naito Foundation. He joined the Company in October 1975. His previous titles include Director of Research & Development Promotion, Chief Director of Research & Development, Managing Director, Senior Managing Director, Vice President and President in the Company.

Ryohei Yanagi

Mr. Ryohei Yanagi has been serving as Managing Executive Officer, Chief Financial Officer and Chief IR Officer in Eisai Co., Ltd. since June 2015. He joined the Company in September 2009. His previous titles include Executive Officer and Director of Investor Relations in the Company. He used to work for UBS Securities Japan Co., Ltd.

Hideki Hayashi

Mr. Hideki Hayashi has been serving as Representative Executive Officer and Chief Information Officer in Eisai Co., Ltd. since April 2016. He joined the Company in April 1981. His previous titles include Vice President, Senior Managing Executive Officer, Managing Executive Officer, Executive Officer and Director of Business Development in the Company.

Junichi Asatani

Mr. Junichi Asatani has been serving as Executive Officer and Chief Compliance Officer in Eisai Co., Ltd. since June 2014. He joined the Company in April 1985. His previous titles include Director of Compliance & Risk Management Promotion and Director of Corporate IA in the Company.

Kenta Takahashi

Mr. Kenta Takahashi has been serving as Managing Executive Officer and General Counsel in Eisai Co., Ltd., as well as President and Representative Director of a subsidiary, Eisai R & D Management Co., Ltd., since April 2016. He joined the Company in April 1983. His previous titles include Executive Officer and Director of Legal Affairs in the Company.

Ivan Cheung

Mr. Ivan Cheung has been serving as Managing Executive Officer, President of Neurology Business Group and President of America Region in Eisai Co., Ltd., as well as Chairman of the Board and Chief Executive Officer of a subsidiary, Eisai Inc., since April 2016. He joined the Company in October 2005. His previous titles include Executive Officer, Director of Promotion in Main Product Creation Unit in CEO's Office, Deputy Chief Director of Human Resources Development, Director of Talent Management and Director of Business Strategy in the Company.

Edward Geary

Mr. Edward Stewart Geary has been serving as Managing Executive Officer, Chief Medical Officer and Chief Director of Corporate Medical Affairs in Eisai Co., Ltd. since June 2013. He joined the Company in April 1997. His previous titles include Executive Officer, Director of Pharmaceutical Business Policy and Deputy Chief Director of Reliability Assurance in the Company. He used to work for Stanford University.

Gary Hendler

Mr. Gary Hendler has been serving as Managing Executive Officer, President of EMEA Region and Chief Commercial Officer of Oncology Business Group in Eisai Co., Ltd., as well as President and Chief Executive Officer of a subsidiary, Eisai Europe Ltd., since April 2016. He previously served as Executive Officer in the Company. He used to work for another subsidiary.

Terushige Iike

Mr. Terushige Iike has been serving as Managing Executive Officer and President of Oncology Business Group in Eisai Co., Ltd. since April 2016. He joined the Company in April 1986. His previous titles include Executive Officer, Director of Corporate Strategy and Director of Clinical Development in the Company. He used to work for a subsidiary.

Masatomi Akana

Mr. Masatomi Akana has been serving as Executive Officer in Eisai Co., Ltd. since June 2017. He joined the Company in April 1990. He previously served as Manager of Secretary Office in the Company.

Yanhui Feng

Ms. Yanhui Feng has been serving as Executive Officer in Eisai Co., Ltd., as well as General Manager of two China-based subsidiaries, including Eisai China Holdings Ltd. and Eisai China Inc., since April 2016. She used to work for another company.

Yasunobu Kai

Mr. Yasunobu Kai has been serving as Executive Officer, Chief Planning Officer of Oncology Business Group and Director of Planning of Oncology Business Group in Eisai Co., Ltd. since June 2018. He joined the Company in April 1986. His previous titles include President of Frontier Drug Development Unit and President of Eisai Value Maximization Systems in the Company.

Shohei Kanazawa

Mr. Shohei Kanazawa has been serving as Executive Officer and President of Consumer hhc Business Unit in Eisai Co., Ltd. since June 2017. He joined the Company in April 1986. He previously served as President of Pharmaceutical Cosmetics Business Unit in the Company.

Hiroyuki Kato

Mr. Hiroyuki Kato has been serving as Executive Officer and Chief Quality Officer in Eisai Co., Ltd. since January 2018. He joined the Company in April 1982. His previous titles include Manager of Medicine Development Center and Director of Portfolio Strategy & Promotion in Main Product Creation Unit in the Company.

Yoshiteru Kato

Mr. Yoshiteru Kato has been serving as Executive Officer and President of Eisai Demand Chain Systems in Eisai Co., Ltd. since June 2017. He joined the Company in April 1988. He previously served as Deputy President of Eisai Demand Chain Systems in the Company.

Teiji Kimura

Mr. Teiji Kimura has been serving as Executive Officer and Chief Discovery Officer of Neurology Business Group in Eisai Co., Ltd. since April 2016. He joined the Company in April 1987. He previously served as Director of Neurology Tsukuba Research Institute in the Company.

Hiroyuki Kobayashi

Mr. Hiroyuki Kobayashi has been serving as Executive Officer, Chief Medical Officer of Japan & Asia and Chief Director of Medical in Eisai Co., Ltd. since June 2017. He joined the Company in January 2016. His previous titles include Director of Neurology Medical Department and Director of Oncology Medical in the Company. He used to work for Otsuka Pharmaceutical Co., Ltd.

Lynn Kramer

Mr. Lynn Kramer has been serving as Executive Officer, Chief Clinical Officer of Neurology Business Group and Chief Medical Officer of Neurology Business Group in Eisai Co., Ltd. since April 2016. He used to work for another company and a subsidiary, Eisai Inc.

Masayuki Miyajima

Mr. Masayuki Miyajima has been serving as Executive Officer and President of Eisai Japan in Eisai Co., Ltd. since April 2016. He joined the Company in April 1985.

Kazumasa Nagayama

Mr. Kazumasa Nagayama has been serving as Executive Officer, Chief Strategy Officer and Director of Corporate Strategy in Eisai Co., Ltd. since June 2018. He joined the Company in April 2002.

Akiko Nakahama

Ms. Akiko Nakahama has been serving as Executive Officer and Manager of Medicine Development Center in Eisai Co., Ltd. since June 2018. She joined the Company in April 1992. She previously served as Senior Director of Japan & Asia Regulatory and Asia Clinical Operations in Medicine Development Center in the Company.

Takashi Ohwa

Mr. Takashi Ohwa has been serving as Executive Officer, Chief Medicine Creation Officer of Oncology Business Group and Chief Discovery Officer of Oncology Business Group in Eisai Co., Ltd. since April 2016. He joined the Company in April 1991. His previous titles include Director of 2nd Drug Development Research Institute and President of Oncology Drug Development Unit in the Company.

Shaji Procida

Ms. Shaji Procida has been serving as Executive Officer in Eisai Co., Ltd., as well as President and Chief Operating Officer of a subsidiary, Eisai Inc., since June 2014. She used to work for another company.

Sayoko Sasaki

Ms. Sayoko Sasaki has been serving as Executive Officer and President of Asia & Latin America Region in Eisai Co., Ltd. since January 2018. She joined the Company in April 1991. Her previous titles include Manager of Global Access Strategy Office, President of Asia Region, Director of PR and Director of Government Relations in the Company.

Alexander Scott

Mr. Alexander Scott has been serving as Executive Officer, Chief Strategy Officer in Neurology Business Group and Director of Strategy in Neurology Business Group in Eisai Co., Ltd. since April 2016. He used to work for another company and a subsidiary, Eisai Inc.

Mitsuaki Tanaka

Mr. Mitsuaki Tanaka has been serving as Executive Officer, Chief Planning Officer and Director of Corporate Planning in Eisai Co., Ltd. since March 2018. He joined the Company in April 1986. His previous titles include Chief Strategy Officer and Director of General Affairs & Environment Safety in the Company.

Hidenori Yabune

Mr. Hidenori Yabune has been serving as Executive Officer and Chief Director of Regional Cooperation Metropolitan Area of Eisai Japan in Eisai Co., Ltd. since April 2017. He joined the Company in April 1994. His previous titles include Director of Integrated Marketing of Eisai Japan and Chief Director of Access & Outcome of Eisai Japan in the Company.

Tatsuyuki Yasuno

Mr. Tatsuyuki Yasuno has been serving as Executive Officer in Eisai Co., Ltd. since March 2018. He joined the Company in April 1991. His previous titles include Director of Corporate Planning & Strategy, Chief Planning Officer and Director of Corporate Planning in the Company.

Yasushi Okada

Mr. Yasushi Okada has been serving as Representative Executive Officer and Chief Talent Officer in Eisai Co., Ltd. since June 2017. He is also working for a fund. He joined the Company in April 1981. His previous titles include Director of Business Planning, Director of Business Promotion in Pharmaceutical Business Unit, Director of Business Strategy in Pharmaceutical Business Unit, Director of Planning in Main Japan Business Main Unit, Executive Officer, Managing Executive Officer and Senior Managing Executive Officer in the Company.

Hirokazu Kanai

Mr. Hirokazu Kanai has been serving as Director in Eisai Co., Ltd. since June 2016. He is also a member of Audit Committee of the Company. He joined the Company in April 1983. His previous titles include Executive Officer, Director of Accounting and Director of Finance & Accounting in the Company.

Noboru Naoe

Mr. Noboru Naoe has been serving as Director in Eisai Co., Ltd. since June 2014. He is also a member of Audit Committee of the Company. He joined the Company in April 1978. His previous titles include Executive Officer, Senior Executive Officer, Managing Executive Officer, Deputy Director of Pharmaceutical Business, Director of Medicine Business, Senior Director of Medicine in Main Japan Business Unit and President of Eisai Japan in the Company.

Yutaka Tsuchiya

Mr. Yutaka Tsuchiya has been serving as Director in Eisai Co., Ltd. since June 2017. He joined the Company in April 1975. His previous titles include Vice President, Executive Officer, Managing Executive Officer, Senior Managing Executive Officer, Representative Executive Officer, Director of Planning in Clinical Test Research Center and Chief Director of Reliability Assurance in the Company. He used to serve as Chairman of the Board and Chief Executive Officer in an United Kingdom-based subsidiary.

Bruce Aronson

Mr. Bruce Aronson has been serving as Independent Director in Eisai Co., Ltd. since June 2017. He is also a member of Nominating Committee, and Chairman of Compensation Committee of the Company. He is also working for University of London, Japan Research Centre and Hitotsubashi University. He used to work for Nagashima Ohno & Tsunematsu, The University of Tokyo, Creighton University, Institute for Monetary and Economic Studies of Bank of Japan and other two law firms.

Shuzo Kaihori

Mr. Shuzo Kaihori has been serving as Independent Director in Eisai Co., Ltd. since June 2018. He is also Chairman of Nominating Committee, and a member of Compensation Committee of the Company. He is also serving as Chairman of the Board of Directors and Director in Yokogawa Electric Corporation, as well as Independent Director in MIP Corporation and HOYA Corporation.

Tamaki Kakizaki

Ms. Tamaki Kakizaki has been serving as Independent Director in Eisai Co., Ltd. since June 2016. She is also a member of Audit Committee of the Company. She is also serving as Independent Director in Mitsubishi Shokuhin Co., Ltd., and working for Japan Airport Terminal Co., Ltd. She is also a Professor of Meiji University. She used to work for Atomi University, Toyo University and Yokohama National University.

Ryuichi Murata

Mr. Ryuichi Murata has been serving as Independent Director in Eisai Co., Ltd. since June 2018. He is also a member of Nominating Committee and Compensation Committee of the Company. He is also serving as Independent Director in Kintetsu Group Holdings Co., Ltd., and working for NORITAKE CO., LIMITED and Mitsubishi UFJ Lease & Finance Company Limited. He used to work for The Bank of Tokyo-Mitsubishi UFJ, Ltd.

Daiken Tsunoda

Mr. Daiken Tsunoda has been serving as Independent Director in Eisai Co., Ltd. since June 2016. He is also a member of Audit Committee of the Company. He is also serving as Independent Director in MS&AD Insurance Group Holdings, Inc. and Culture Convenience Club Co., Ltd., as well as Partner in Nakamura, Tsunoda & Matsumoto, and working for SLEEP SELECT Co., Ltd. and BILCOM, Inc. He used to work for ATLUS Co., Ltd., Polaris Capital Group Co., Ltd. and Japan Stockholders Data Service Company, Limited.

Hideyo Uchiyama

Mr. Hideyo Uchiyama has been serving as Independent Director in Eisai Co., Ltd. since June 2018. He is also a member of Audit Committee of the Company. He is also working for ASAHI Tax Corporation, OMRON Corporation and Sompo Holdings, Inc. He used to work for Arthur Young & Company, KPMG AZSA LLC, KPMG Japan and KPMG AZSA LLC. He is a Certified Public Accountant.

Shinya Watanabe